Syndax Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company engaged in the development of cancer therapies. Its product candidates include SNDX-5613 and SNDX-6352. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in Waltham, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
184
Frequently Asked Questions
What is Market Cap of Syndax Pharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Syndax Pharmaceuticals Inc market cap is $1.66B.
What is the 52-week high for Syndax Pharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Syndax Pharmaceuticals Inc 52 week high is $25.34 as of June 09, 2024.
What is the 52-week low for Syndax Pharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Syndax Pharmaceuticals Inc 52 week low is $11.22 as of June 09, 2024.
What is Syndax Pharmaceuticals Inc stock price today?
Syndax Pharmaceuticals Inc stock price today is $19.50.
What was Syndax Pharmaceuticals Inc stock price yesterday?
Syndax Pharmaceuticals Inc stock price yesterday was $19.40.
What is the PE ratio of Syndax Pharmaceuticals Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Syndax Pharmaceuticals Inc’s P/E ratio is -6.05.
What is the Price-to-Book ratio of Syndax Pharmaceuticals Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Syndax Pharmaceuticals Inc P/B ratio is 3.3689.
What is Syndax Pharmaceuticals Inc's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Syndax Pharmaceuticals Inc's EBITDA is -6.06.
What is the 50-day moving average of Syndax Pharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Syndax Pharmaceuticals Inc 50-day moving average is $21.28.
How many employess does Syndax Pharmaceuticals Inc has?